Cargando…

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual

BACKGROUND: Homozygosity (Δ32/Δ32) for the 32 bp deletion in the chemokine receptor 5 (CCR5) gene is associated with strong resistance against HIV infection. Heterozygosity is associated with protection of HIV-1 disease progression. METHODOLOGY/PRINCIPAL FINDINGS: We genotyped a population of 737 HI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Djin-Ye, Jessen, Heiko, Kücherer, Claudia, Neumann, Konrad, Oh, Nari, Poggensee, Gabriele, Bartmeyer, Barbara, Jessen, Arne, Pruss, Axel, Schumann, Ralf R., Hamouda, Osamah
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453227/ https://www.ncbi.nlm.nih.gov/pubmed/18648518 http://dx.doi.org/10.1371/journal.pone.0002747

Ejemplares similares

CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019)

The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)

Association between the CCR5Δ32 polymorphism and preeclampsia
por: Paula Telini, Bianca de, et al.
Publicado: (2014)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Effect of CCR5-Δ32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis
por: Liu, SiJie, et al.
Publicado: (2012)

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
por: Jensen, Björn-Erik Ole, et al.
Publicado: (2023)

Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer’s disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer’s disease)
por: Khorram Khorshid, Hamid Reza, et al.
Publicado: (2012)

CCR2-64I and CCR5Δ32 Polymorphisms in Korean Patients with Myasthenia Gravis
por: Kim, Hyun Sook, et al.
Publicado: (2007)

Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran
por: Heydarifard, Zahra, et al.
Publicado: (2017)

The CCR5Δ32 Polymorphism in Brazilian Patients with Sickle Cell Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2014)

The association between CCR5 Δ32 polymorphism and susceptibility to breast cancer
por: Li, Junlong, et al.
Publicado: (2017)

Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
por: Li, Ting, et al.
Publicado: (2019)

CCR5-Δ32 gene variant frequency in the Turkish Cypriot population
por: Fahrioglu, Umut, et al.
Publicado: (2020)

Generation of human induced pluripotent stem cells from individuals with a homozygous CCR5Δ32 mutation
por: Chen, Guibin, et al.
Publicado: (2019)

TALENs-mediated homozygous CCR5Δ32 mutations endow CD4(+) U87 cells with resistance against HIV-1 infection
por: Yu, Ai Qing, et al.
Publicado: (2018)

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
por: Huyveneers, Laura E. P., et al.
Publicado: (2022)

Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?
por: Arababadi, Mohammad K., et al.
Publicado: (2009)

CCR5Δ32 mutations do not determine COVID-19 disease course
por: Bernas, Stefanie N., et al.
Publicado: (2021)

COVID-19 prevalence and mortality is associated with the allele frequency of CCR5-Δ32
por: Saadat, Mostafa
Publicado: (2021)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia
por: Chelbi, Hanen, et al.
Publicado: (2021)

Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Δ32 Deletion
por: Parczewski, Milosz, et al.
Publicado: (2011)

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
por: Gupta, Ravindra Kumar, et al.
Publicado: (2020)

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2011)

Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?
por: Starčević Čizmarević, Nada, et al.
Publicado: (2020)

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
por: Tene, Oren, et al.
Publicado: (2021)

CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus
por: Ndikom, Basil Chukwuebuka, et al.
Publicado: (2022)

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards
por: Veloso, Sergi, et al.
Publicado: (2010)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR
por: Sorokina, Alyona, et al.
Publicado: (2022)

CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population
por: Kulmann-Leal, Bruna, et al.
Publicado: (2021)

Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity—A Preliminary Report
por: Ganczak, Maria, et al.
Publicado: (2017)

Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
por: Qi, Chunxia, et al.
Publicado: (2018)

Low prevalence of CCR5-Δ32, CCR2-64I and SDF1-3′A alleles in the Baiga and Gond tribes of Central India
por: Bharti, Deepak, et al.
Publicado: (2015)

CCR5Δ32 Genotype Leads to a Th2 Type Directed Immune Response in ESRD Patients
por: Muntinghe, Friso L. H., et al.
Publicado: (2012)

CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation
por: Panda, Aditya K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p1icmvr2kva7te8ateo0v2qudi